Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis

被引：0
作者：
Rajendra Babu Veeri
Ashok Kumar Gupta
Biplab Pal
Niyamat Ali Siddiqui
Devi Priya
Pradeep Das
Krishna Pandey
机构：
[1] National Institute of Pharmaceutical Education and Research (NIPER),Department of Pharmacy Practice
[2] Rajendra Memorial Research Institute of Medical Sciences (RMRIMS),Department of Bio Statistics
[3] Rajendra Memorial Research Institute of Medical Sciences (RMRIMS),Department of Molecular Biology
[4] Rajendra Memorial Research Institute of Medical Sciences (RMRIMS),Department of Clinical Medicine
来源：
Health and Quality of Life Outcomes | / 17卷
关键词：
Quality of life; Visceral leishmaniasis; WHOQOL-BREF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 110 条
[1]  
Ready PD(2014)Epidemiology of visceral leishmaniasis Clin Epidemiol 6 147-85
[2]  
Sundar S(2015)Visceral leishmaniasis Trop Parasitol 5 83-245
[3]  
Desjeux P(1992)Human leishmaniasis: epidemiology and public health aspects World Health Stat Q 45 267-325
[4]  
Matlashewski G(2011)Visceral leishmaniasis: elimination with existing interventions Lancet Infect Dis 11 322-109
[5]  
Arana B(2016)Recent developments and future prospects in the treatment of visceral leishmaniasis Ther Adv Infect Dis 3 98-68
[6]  
Kroeger A(1999)Epidemiology of visceral leishmaniasis in India Natl Med J India 12 62-172
[7]  
Battacharya S(2004)Epidemiological, clinical and pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India Indian J Med Res 120 166-550
[8]  
Sundar S(2012)Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use Clin Infect Dis 55 543-383
[9]  
Das P(2015)Effectiveness study of Paromomycin IM injection (PMIM) for the treatment of visceral Leishmaniasis (VL) in Bangladesh PLoS Neglected Tropical Disease 9 377-512
[10]  
Sundar S(2004)Amphotericin B treatment for Indian visceral Leishmaniasis: conventional versus lipid formulations Clin Infect Dis 38 504-153
12345678910